1,3-Diethyl-5-(3-methyl-thiophen-2-ylmethylene)-2-thioxo-dihydro-pyrimidine-4,6-dione

ID: ALA150651

PubChem CID: 4449347

Max Phase: Preclinical

Molecular Formula: C14H16N2O2S2

Molecular Weight: 308.43

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN1C(=O)C(=Cc2sccc2C)C(=O)N(CC)C1=S

Standard InChI:  InChI=1S/C14H16N2O2S2/c1-4-15-12(17)10(8-11-9(3)6-7-20-11)13(18)16(5-2)14(15)19/h6-8H,4-5H2,1-3H3

Standard InChI Key:  TURLRBKLRFQGTA-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 20 21  0  0  0  0  0  0  0  0999 V2000
    9.5500    1.2208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1375    0.3708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1250    1.1958    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8625   -0.0292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8250    1.6208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5667    0.3958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2542    1.6458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9792    1.2458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7167    1.6000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0792    0.4333    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    7.4292   -0.0542    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.8125    2.4458    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.2917    0.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.8875    0.2750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2792    1.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8292   -0.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4125    1.6333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8667    2.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5292   -1.2917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6875    1.2333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  4  1  0
  3  5  1  0
  4  6  1  0
  5  1  1  0
  6  1  1  0
  7  1  2  0
  8  7  1  0
  9  8  2  0
 10  8  1  0
 11  2  2  0
 12  5  2  0
 13  6  2  0
 14 10  1  0
 15  9  1  0
 16  4  1  0
 17  3  1  0
 18  9  1  0
 19 16  1  0
 20 17  1  0
  2  3  1  0
 15 14  2  0
M  END

Associated Targets(Human)

TNFRSF1A Tchem Tumor necrosis factor receptor R1 (157 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 308.43Molecular Weight (Monoisotopic): 308.0653AlogP: 2.44#Rotatable Bonds: 3
Polar Surface Area: 40.62Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.26CX LogD: 3.26
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.49Np Likeness Score: -1.62

References

1. Voss ME, Carter PH, Tebben AJ, Scherle PA, Brown GD, Thompson LA, Xu M, Lo YC, Yang G, Liu RQ, Strzemienski P, Everlof JG, Trzaskos JM, Decicco CP..  (2003)  Both 5-arylidene-2-thioxodihydropyrimidine-4,6(1H,5H)-diones and 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones are light-dependent tumor necrosis factor-alpha antagonists.,  13  (3): [PMID:12565966] [10.1016/s0960-894x(02)00941-1]

Source